Plasma complement component 4 increases in patients with major depressive disorder

Jinxue Wei,* Ye Liu,* Liansheng Zhao, Xiao Yang, Peiyan Ni, Yingcheng Wang, Tao Li, Xiaohong Ma Psychiatric Laboratory and Mental Health Center, Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China *These authors contributed equally to this work Abstract: Elevati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wei J, Liu Y, Zhao L, Yang X, Ni P, Wang Y, Li T, Ma X
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/fdb3bdda310f47f89b58f411a6db34eb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fdb3bdda310f47f89b58f411a6db34eb
record_format dspace
spelling oai:doaj.org-article:fdb3bdda310f47f89b58f411a6db34eb2021-12-02T01:24:56ZPlasma complement component 4 increases in patients with major depressive disorder1178-2021https://doaj.org/article/fdb3bdda310f47f89b58f411a6db34eb2017-12-01T00:00:00Zhttps://www.dovepress.com/plasma-complement-component-4-increases-in-patients-with-major-depress-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Jinxue Wei,* Ye Liu,* Liansheng Zhao, Xiao Yang, Peiyan Ni, Yingcheng Wang, Tao Li, Xiaohong Ma Psychiatric Laboratory and Mental Health Center, Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China *These authors contributed equally to this work Abstract: Elevation of plasma inflammatory factors in major depressive disorder (MDD) has been repeatedly observed, but contradictory results have also been reported. Alteration of complement components in MDD may also contribute to the pathophysiology of MDD by participating in inflammation. The recent findings that complement component 4 (C4) was involved in neural synapse elimination and associated with schizophrenia implicated the potential roles of C4 in MDD. In this study, we analyzed the plasma concentration of complement C4 and inflammatory factors, including interleukin (IL)-1β, IL-6, IL-8, IL-10, interferon-α, interferon-γ and tumor necrosis factor-α, of 53 patients with MDD and 60 healthy individuals. The plasma of 17 patients out of 51 after antidepressant medication was also collected for analysis. The results showed that peripheral C4 in MDD was higher than that in healthy controls. No significant correlation of inflammatory factors or C4 with depressive or anxiety symptoms was found. Antidepressant medication significantly reduced plasma C4 of patients with MDD. Our results were consistent with previous findings that complement components were elevated in MDD and suggested that C4 might play a role in pathophysiology of MDD and could be a candidate in the research of biomarker and the pathophysiology of MDD. Keywords: depression, C4, inflammationWei JLiu YZhao LYang XNi PWang YLi TMa XDove Medical Pressarticlemajor depressive disordercomplement component 4inflammatory factorsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 37-41 (2017)
institution DOAJ
collection DOAJ
language EN
topic major depressive disorder
complement component 4
inflammatory factors
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle major depressive disorder
complement component 4
inflammatory factors
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Wei J
Liu Y
Zhao L
Yang X
Ni P
Wang Y
Li T
Ma X
Plasma complement component 4 increases in patients with major depressive disorder
description Jinxue Wei,* Ye Liu,* Liansheng Zhao, Xiao Yang, Peiyan Ni, Yingcheng Wang, Tao Li, Xiaohong Ma Psychiatric Laboratory and Mental Health Center, Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China *These authors contributed equally to this work Abstract: Elevation of plasma inflammatory factors in major depressive disorder (MDD) has been repeatedly observed, but contradictory results have also been reported. Alteration of complement components in MDD may also contribute to the pathophysiology of MDD by participating in inflammation. The recent findings that complement component 4 (C4) was involved in neural synapse elimination and associated with schizophrenia implicated the potential roles of C4 in MDD. In this study, we analyzed the plasma concentration of complement C4 and inflammatory factors, including interleukin (IL)-1β, IL-6, IL-8, IL-10, interferon-α, interferon-γ and tumor necrosis factor-α, of 53 patients with MDD and 60 healthy individuals. The plasma of 17 patients out of 51 after antidepressant medication was also collected for analysis. The results showed that peripheral C4 in MDD was higher than that in healthy controls. No significant correlation of inflammatory factors or C4 with depressive or anxiety symptoms was found. Antidepressant medication significantly reduced plasma C4 of patients with MDD. Our results were consistent with previous findings that complement components were elevated in MDD and suggested that C4 might play a role in pathophysiology of MDD and could be a candidate in the research of biomarker and the pathophysiology of MDD. Keywords: depression, C4, inflammation
format article
author Wei J
Liu Y
Zhao L
Yang X
Ni P
Wang Y
Li T
Ma X
author_facet Wei J
Liu Y
Zhao L
Yang X
Ni P
Wang Y
Li T
Ma X
author_sort Wei J
title Plasma complement component 4 increases in patients with major depressive disorder
title_short Plasma complement component 4 increases in patients with major depressive disorder
title_full Plasma complement component 4 increases in patients with major depressive disorder
title_fullStr Plasma complement component 4 increases in patients with major depressive disorder
title_full_unstemmed Plasma complement component 4 increases in patients with major depressive disorder
title_sort plasma complement component 4 increases in patients with major depressive disorder
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/fdb3bdda310f47f89b58f411a6db34eb
work_keys_str_mv AT weij plasmacomplementcomponent4increasesinpatientswithmajordepressivedisorder
AT liuy plasmacomplementcomponent4increasesinpatientswithmajordepressivedisorder
AT zhaol plasmacomplementcomponent4increasesinpatientswithmajordepressivedisorder
AT yangx plasmacomplementcomponent4increasesinpatientswithmajordepressivedisorder
AT nip plasmacomplementcomponent4increasesinpatientswithmajordepressivedisorder
AT wangy plasmacomplementcomponent4increasesinpatientswithmajordepressivedisorder
AT lit plasmacomplementcomponent4increasesinpatientswithmajordepressivedisorder
AT max plasmacomplementcomponent4increasesinpatientswithmajordepressivedisorder
_version_ 1718403113849716736